CARE Ratings Ltd
CARE Ratings is a leading credit rating agency of India. The Company provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own riskreturn expectations.(Source : 202003-01 Annual Report Page No:134)
- Market Cap ₹ 3,680 Cr.
- Current Price ₹ 1,230
- High / Low ₹ 1,265 / 831
- Stock P/E 35.6
- Book Value ₹ 240
- Dividend Yield 1.46 %
- ROCE 20.6 %
- ROE 14.5 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 69.8%
Cons
- The company has delivered a poor sales growth of 0.78% over past five years.
- Company has a low return on equity of 13.1% over last 3 years.
- Earnings include an other income of Rs.47.0 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Credit Rating Agencies Industry: Miscellaneous
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
203 | 236 | 261 | 279 | 287 | 333 | 319 | 244 | 248 | 248 | 279 | 332 | 344 | |
68 | 88 | 101 | 105 | 105 | 122 | 144 | 162 | 153 | 168 | 180 | 220 | 228 | |
Operating Profit | 135 | 148 | 160 | 174 | 182 | 211 | 175 | 81 | 96 | 80 | 99 | 112 | 116 |
OPM % | 66% | 63% | 61% | 62% | 63% | 63% | 55% | 33% | 39% | 32% | 36% | 34% | 34% |
29 | 36 | 44 | 9 | 34 | 25 | 30 | 31 | 31 | 27 | 38 | 47 | 47 | |
Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 |
Depreciation | 3 | 3 | 5 | 4 | 3 | 3 | 3 | 8 | 8 | 8 | 11 | 10 | 11 |
Profit before tax | 160 | 181 | 197 | 178 | 212 | 233 | 202 | 104 | 119 | 99 | 126 | 147 | 151 |
Tax % | 29% | 28% | 30% | 33% | 31% | 30% | 32% | 20% | 23% | 22% | 32% | 30% | |
114 | 130 | 138 | 120 | 148 | 162 | 138 | 83 | 91 | 77 | 85 | 103 | 106 | |
EPS in Rs | 39.78 | 44.63 | 47.53 | 40.68 | 50.13 | 55.13 | 46.66 | 27.96 | 30.39 | 25.34 | 28.12 | 33.67 | 34.70 |
Dividend Payout % | 50% | 63% | 166% | 69% | 56% | 100% | 64% | 70% | 56% | 67% | 89% | 53% |
Compounded Sales Growth | |
---|---|
10 Years: | 3% |
5 Years: | 1% |
3 Years: | 10% |
TTM: | 18% |
Compounded Profit Growth | |
---|---|
10 Years: | -1% |
5 Years: | -6% |
3 Years: | 4% |
TTM: | 18% |
Stock Price CAGR | |
---|---|
10 Years: | -1% |
5 Years: | 18% |
3 Years: | 21% |
1 Year: | 28% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 14% |
3 Years: | 13% |
Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 30 | 30 | 30 |
Reserves | 396 | 456 | 330 | 379 | 491 | 567 | 521 | 504 | 559 | 618 | 643 | 687 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 9 | 17 | 20 | |
84 | 96 | 87 | 94 | 64 | 61 | 64 | 85 | 74 | 69 | 80 | 105 | |
Total Liabilities | 508 | 581 | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 |
58 | 59 | 65 | 64 | 61 | 60 | 83 | 93 | 85 | 96 | 107 | 109 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 8 | 4 | 6 |
Investments | 381 | 459 | 335 | 381 | 466 | 518 | 439 | 339 | 240 | 44 | 44 | 44 |
69 | 63 | 46 | 58 | 57 | 79 | 93 | 185 | 343 | 577 | 614 | 683 | |
Total Assets | 508 | 581 | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
83 | 107 | 107 | 106 | 119 | 134 | 109 | 67 | 86 | 68 | 82 | 91 | |
-87 | -46 | 157 | -41 | -22 | -25 | 83 | 27 | -38 | -27 | 13 | -39 | |
-40 | -62 | -276 | -66 | -96 | -99 | -195 | -107 | -43 | -35 | -63 | -63 | |
Net Cash Flow | -44 | -1 | -12 | -1 | 1 | 11 | -4 | -13 | 5 | 6 | 32 | -11 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 40 | 23 | 22 | 31 | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 40 | 23 | 22 | 31 | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 |
Working Capital Days | -85 | -100 | -82 | -65 | -10 | -1 | 13 | 14 | 1 | 640 | 641 | 594 |
ROCE % | 37% | 36% | 39% | 46% | 44% | 41% | 35% | 19% | 21% | 16% | 19% | 21% |
Documents
Announcements
-
Board Meeting Intimation for (A) Consider And Approve The Unaudited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024;
(B) Consider Declaration Of Interim Dividend, If Any, For The Financial Year 2024-25.
1d - Board meeting to approve financial results and interim dividend.
- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 7 Oct
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 3 Oct
-
Closure of Trading Window
27 Sep - Closure of trading window for CARE Ratings securities.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 24 Sep
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Concalls
-
Aug 2024TranscriptNotesPPT
-
May 2024Transcript PPT
-
Jan 2024TranscriptNotesPPT
-
Oct 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Jan 2023TranscriptNotesPPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Jul 2022TranscriptNotesPPT
-
Jul 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020Transcript PPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
May 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Jan 2018TranscriptNotesPPT
-
Jan 2018TranscriptNotesPPT
-
Nov 2017TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
May 2016TranscriptNotesPPT
-
Feb 2016TranscriptNotesPPT
-
Nov 2015TranscriptNotesPPT
-
Jul 2015TranscriptNotesPPT
About
CARE was incorporated in 1993 and is one of
the leading credit rating agencies in India. The company is professionally managed and is a leader in corporate ratings and enjoys a dominant position in PSU ratings.[1] CareEdge Ratings is a leader in rating Financial and Infrastructure sector.[2]